L-DOPAlevodopaParkinson’s diseasedopaminergic therapyPDDDS
…e a female with young-onset PD who progressively escalated oral L-DOPA intake to a peak of 10 000 mg/day prior to subthalamic nucleus …
1articles mentioning drugs
4drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: L-DOPA ×
L-DOPA
This drug is selected. Its supporting articles are shown below.